Secondary prevention of myocardial infarct.

Authors

  • A L Santos UTIC-Arsénio Cordeiro, Hospital de Santa Maria, Lisboa.

DOI:

https://doi.org/10.20344/amp.2251

Abstract

Preventive measures are the most powerful measures to treat manifestations of ischemic cardiopathy. Secondary prevention of myocardial infarction involves the following intervention areas: a) Limitation of adverse physiological and emotional consequences of the acute illness; b) Identification of the patients particularly exposed to the risk of new episodes of ischemic cardiopathy or to their consequences, namely reinfarction and sudden death; c) Institution of therapeutic attitudes, surgical or medical, that can prolong life and can oppose functional deterioration and prevent symptoms; d) Institution of measures that can oppose the progression of the initial disease that is, in almost all cases, atherosclerosis. Measures that can oppose the progression of cardiac disease and its consequences after an episode of myocardial infarction, and measures that can oppose the evolution of atherosclerosis are described in this article. The measures that can influence the risk factors after an episode of myocardial infarction are briefly commented: characteristics related to life style and physical exercise; smoking habits; plasmatic lipid levels; high blood pressure; and therapeutic substitution with estrogens after menopause. Pharmacological interventions in secondary prevention of myocardial infarction are described, namely with the following groups of substances: beta-adrenergic blocking agents; platelet active agents; anticoagulants; and angiotensin-converting enzyme inhibitors.

Downloads

Download data is not yet available.

How to Cite

1.
Santos AL. Secondary prevention of myocardial infarct. Acta Med Port [Internet]. 1998 May 30 [cited 2024 Mar. 28];11(5):483-91. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/2251

Issue

Section

Arquivo Histórico